Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Stephanie L Graff"'
Autor:
Shivani Majmudar, Stephanie L Graff, Marah Kays, Beatriz X Braz, Laurie Matt-Amaral, Merry J Markham, Ishwaria M Subbiah, Emily Bergsland, Shikha Jain
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e47784 (2023)
The COVID-19 pandemic exacerbated gender inequity in medicine, with women physicians reporting greater household responsibilities than their men counterparts and steeper barriers to career advancement. The pandemic highlighted the systemic assumption
Externí odkaz:
https://doaj.org/article/8b46f7e212da49b9b83314a8d1c6bee7
Autor:
Stephanie L. Graff, Tanya Wildes, Narjust Duma, Don S. Dizon, Noelle K. LoConte, Edith Mitchell, Martina C. Murphy, Edith A. Perez, Sarah M. Temkin, Pamela L. Kunz, Karen M. Winkfield
Publikováno v:
Journal of Clinical Oncology. 41:1350-1358
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::630472746a1cae984856ecb6b284ba25
https://doi.org/10.1200/jco.22.01060
https://doi.org/10.1200/jco.22.01060
Autor:
Rani Bansal, Julie McGrath, Phil Walker, Matias A. Bustos, Estelamari Rodriguez, Sarah L. Sammons, Melissa K. Accordino, Jane Meisel, Margaret Gatti-Mays, Emily Hsu, Kate I. Lathrop, Virginia Kaklamani, Matthew Oberley, W. Michael Korn, Stephanie L. Graff
Publikováno v:
Cancer Research. 83:HER2-12
Introduction: Breast cancer has pioneered precision medicine with prognostic and predictive subtypes, defined by immunohistochemistry (IHC). Novel therapeutic strategies have led to the emergence of HER2-Low (H2L) as a new entity, defined as tumors w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc0073405ba9abbea9f85683cd012286
https://doi.org/10.1158/1538-7445.sabcs22-her2-12
https://doi.org/10.1158/1538-7445.sabcs22-her2-12
Publikováno v:
Advances in Breast Cancer Research. 12:27-50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a580daa266631875193d3f3f7ccc73b1
https://doi.org/10.4236/abcr.2023.122004
https://doi.org/10.4236/abcr.2023.122004
Autor:
Anusha Chidharla, Audun Utengen, Deanna J. Attai, Emily K. Drake, G.J. van Londen, Ishwaria M. Subbiah, Elizabeth Henry, Martina Murphy, Maura M. Barry, Rami Manochakian, Scott Moerdler, Stacy Loeb, Stephanie L. Graff, Yan Leyfman, Michael A. Thompson, Merry J. Markham
Publikováno v:
JCO oncology practice. 18(8)
The use of social media continues to increase in health care and academia. Health care practice, particularly the oncologic field, is constantly changing because of new knowledge, evidence-based research, clinical trials, and government policies. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fddc5a74c9f87d526695ba90d80dc54d
https://pubmed.ncbi.nlm.nih.gov/35312343
https://pubmed.ncbi.nlm.nih.gov/35312343
Autor:
Whitney L. Hensing, Joanne Xiu, W. Michael Korn, Stephanie L. Graff, Irene Kang, Evanthia T. Roussos Torres, Arielle L. Heeke, Andrew A. Davis, Nusayba A. Bagegni, Katherine K. Clifton, Ron Bose, Cynthia Ma, Foluso O. Ademuyiwa
Publikováno v:
Cancer Research. 83:P3-05
Introduction: Estrogen receptor (ER) loss occurs in about 20% of recurrent breast cancers (BC) and is associated with unresponsiveness to endocrine therapy (ET) and poor prognosis. Prior studies evaluating ER-loss included predominately patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5bcb7bc3af3f89462dd933887a3c847
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-08
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-08
Autor:
Andrea, Anampa-Guzmán, Janet, Freeman-Daily, Michael, Fisch, Emil, Lou, Nathan A, Pennell, Corrie A, Painter, Dorinda, Sparacio, Mark A, Lewis, Maimah, Karmo, Patricia F, Anderson, Stephanie L, Graff
Publikováno v:
JCO Oncology Practice. 18:578-583
PURPOSE: Patients who have cancer have leveraged the Internet to gain a better understanding of their disease and connect across geographic boundaries with others facing the same challenges. Online cancer communities have developed into resources tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c456a29c247305bc02b4cb5916fe435f
https://doi.org/10.1200/op.21.00763
https://doi.org/10.1200/op.21.00763
Autor:
Rachel A. Freedman, Stephanie L. Graff, Mark R. Somerfield, Melinda L. Telli, Antonio C. Wolff, Sharon H. Giordano
Publikováno v:
JCO Oncology Practice. 18:516-519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df8a01be675919c64f777dc67d1af56a
https://doi.org/10.1200/op.22.00140
https://doi.org/10.1200/op.22.00140
Publikováno v:
Clinical Breast Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::166e0d7ce677b72e83a4e8536a8cef07
https://doi.org/10.1016/j.clbc.2023.05.003
https://doi.org/10.1016/j.clbc.2023.05.003
Significant advances in breast cancer (BC) treatment have been made in the last decade, including the use of immunotherapy and, in particular, immune checkpoint inhibitors that have been shown to improve the survival of patients with triple negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6d45de33ea207314b8dc2df47adc56
https://hdl.handle.net/10400.14/41260
https://hdl.handle.net/10400.14/41260
